Vertex Pharmaceuticals has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA), which is an agreement in…
Articles by Steve Bryson, PhD
Researchers at the Children’s Hospital Colorado Breathing Institute are participating in four new studies to evaluate the long-term impact of…
Kaftrio successfully improved lung function and quality of life in three Italian cystic fibrosis (CF) patients who have severe…
Vertex Pharmaceuticals is initiating two Phase 3 clinical trials into the safety and efficacy of a potentially new, next-generation…
Most primary care providers (PCPs) in Ontario — family physicians, pediatricians, and midwives — voiced a willingness and confidence in…
Inflammation in the airways of people with cystic fibrosis (CF) regulates the pH of the surface liquid and increases…
Vertex Pharmaceuticals has reached reimbursement agreements with health authorities in France and Italy for its various cystic fibrosis (CF)…
Reduced levels of the VIP hormone in the pancreas due to low nerve supply may contribute to the development of…
Two months of treatment with Kalydeco (ivacaftor) by cystic fibrosis…
Human mesenchymal stem cells (hMSCs) effectively treated infections caused by non-tuberculous mycobacteria in cell-based tests and a mouse…